HANS W SOLLINGER, MD PHD
Radiology at Highland Ave, Madison, WI
License number
Wisconsin 22931
Category
Radiology
Type
Transplant Surgery
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 262-5420
(608) 262-5624 (Fax)
(608) 262-5624 (Fax)
Organization information
See more information about HANS W SOLLINGER at bizstanding.comUniversity-Wisconsin HSPTLS - Hans W Sollinger MD
600 Highland Ave #H5, Madison, WI 53792
Categories:
Pediatrics Physicians & Surgeons, Physicians & Surgeons
Phone:
(608) 262-5420 (Phone)
Products:
Military & Veteran Services
Additional:
Allergy Asthma & Immunology, Adult & Pediatric
Professional information
Dr. Hans W Sollinger, Madison WI - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
600 Highland Ave, Madison 53792
(608) 262-5420 (Phone)
UW Health Transplant Srgry Clnc
600 Highland Ave STE G7105, Madison 53792
(608) 263-1004 (Phone)
(608) 262-5420 (Phone)
UW Health Transplant Srgry Clnc
600 Highland Ave STE G7105, Madison 53792
(608) 263-1004 (Phone)
Procedures:
Colectomy, Dressing and/or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy), Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Gallbladder Removal, Laparoscopic, Incisional/Ventral Hernia Repair, Open, Inguinal Hernia Repair, Open, Intestinal Transplant (incl. Enterectomy), Pancreatectomy (incl. Pancreas Transplant & Whipple Procedure), Peripheral Artery Catheterization, Renal Transplant and Nephrectomy, Splenectomy, Splenectomy and Splenorrhaphy, Tracheal Surgery, Umbilical or Ventral Hernia Repair, Laparoscopic
Conditions:
Appendicitis, Breast Cancer, Carcinoma in Situ, Cerebrospinal Fluid Leak (CSF Leak), Cholecystitis and Gallstones, Diaphragmatic/Hiatal Hernia, Hemorrhoids, Hyperparathyroidism, Incisional Hernia, Inguinal Hernia, Intestinal Obstruction, Parathyroid (Gland) Disease, Peripheral Arterial Aneurysm and Dissection, Peripheral Vascular Disease (PAD, PVD), Phlebitis and Thrombophlebitis, Umbilical Hernia
Certifications:
General Surgery, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 Highland Ave, Madison 53792
UW Health Transplant Srgry Clnc
600 Highland Ave STE G7105, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
UW Health Transplant Srgry Clnc
600 Highland Ave STE G7105, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
Ludwig-Maximilians-Universitaet Munchen, Fachbereich Medizin
Graduated: 1974
Ludwig-Maximilians-Universitaet Munchen, Fachbereich Medizin
Graduated: 1974
Founder And Ceo At Insulete
Position:
Founder and CEO at INSULETE, Professor and Chair at University of Wisconsin, Professor of Surgery at University of Wisconsin
Location:
Madison, Wisconsin
Industry:
Hospital & Health Care
Work:
INSULETE
- Madison,Wisconsin since Jan 2004
-
Founder and CEO
University of Wisconsin
since Jul 1980
-
Professor and Chair
University of Wisconsin
since 1980
-
Professor of Surgery
University of Wisconsin-Madison
- University of Wisconsin Sep 1995 - Nov 2008
-
Professor and Chair of Transplant
Education:
University of Munich 1967 - 1973
MD, Medicine
MD, Medicine
Interests:
Long-distance Road Bike riding and Cross Country Skiing.
Detection Of B-Cell Activating Factor As A Biomarker For Antibody Mediated Rejection In Transplant Recipients
US Patent:
2012026, Oct 18, 2012
Filed:
Oct 25, 2010
Appl. No.:
13/501671
Inventors:
Debra D. Bloom - Sun Prairie WI, US
Hans W. Sollinger - Madison WI, US
Arjang Djamali - Cross Plains WI, US
Hans W. Sollinger - Madison WI, US
Arjang Djamali - Cross Plains WI, US
Assignee:
WISCONSIN ALUMNI RESEARCH FOUNDATION - Madison WI
International Classification:
G01N 33/566
US Classification:
435 724, 435 792
Abstract:
The invention relate to methods, compositions, and kits for detection of biomarkers. hi one embodiment, the invention relates to a method for detecting AMR biomarkers in a biological sample. In another embodiment, the invention relates to a method for detecting, monitoring, diagnosing and predicting antibody mediated rejection. In yet another embodiment, the invention relates to a method for monitoring a subject for antibody mediated rejection comprising detecting BAFF or a BAFF variant in a biological sample. In still another embodiment, the invention relates to a kit for detecting BAFF in a urine sample.
Treatment Of Diabetes With Synthetic Beta Cells
US Patent:
6933133, Aug 23, 2005
Filed:
Nov 12, 2001
Appl. No.:
10/013032
Inventors:
Tausif Alam - Madison WI, US
Debra A. Hullett - Madison WI, US
Hans W. Sollinger - Madison WI, US
Debra A. Hullett - Madison WI, US
Hans W. Sollinger - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12P021/04, C12P021/06, C12N015/74, C12N015/87, C12N005/00, C12N048/00
US Classification:
435 691, 435 696, 4353201, 435325, 435455, 514 44, 424 932, 424 9321
Abstract:
Disclosed is a method for obtaining glucose-regulated expression of active insulin in the cells of a mammalian subject. The method involves delivering into the subject a genetic construct comprising a coding sequence for a human proinsulin operably connected a promoter functional in the host cells. The construct includes a glucose responsive regulatory module having at least one glucose inducible regulatory element comprising a pair of CACGTG motifs linked by a five base nucleotide sequence, which confers glucose inducible expression of the proinsulin coding sequence. To ensure proper processing of the proinsulin to active insulin, the coding sequence was modified to direct the synthesis of a mutant proinsulin polypeptide having amino acid sequences that can be cleaved to mature insulin in suitable host cells, such as hepatocytes.
Use Of Vitamin D Compounds To Prevent Transplant Rejection
US Patent:
6071897, Jun 6, 2000
Filed:
Jul 15, 1998
Appl. No.:
9/115958
Inventors:
Hector F. DeLuca - Deerfield WI
Margherita T. Cantorna - Middleton WI
Colleen E. Hayes - Madison WI
Debra A. Hullett - Madison WI
Hans W. Sollinger - Madison WI
Margherita T. Cantorna - Middleton WI
Colleen E. Hayes - Madison WI
Debra A. Hullett - Madison WI
Hans W. Sollinger - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 3159
US Classification:
514167
Abstract:
A method of moderating transplant rejection in a transplant recipient comprising administering a dose of vitamin D compound effective to prevent transplant rejection is disclosed. Preferably, the recipient's susceptibility to opportunistic infections has not been compromised. Also preferably, the recipient has not suffered bone demineralization.
Treatment Of Diabetes With Synthetic Beta Cells
US Patent:
7425443, Sep 16, 2008
Filed:
May 12, 2005
Appl. No.:
11/127629
Inventors:
Tausif Alam - Madison WI, US
Debra A. Hullett - Madison WI, US
Hans W. Sollinger - Madison WI, US
Debra A. Hullett - Madison WI, US
Hans W. Sollinger - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 15/00, A01N 63/00
US Classification:
4353201, 424 932, 424 9321, 536 235, 536 241
Abstract:
Disclosed is a method for obtaining glucose-regulated expression of active insulin in the cells of a mammalian subject. The method involves delivering into the subject a genetic construct comprising a coding sequence for a human proinsulin operably connected a promoter functional in the host cells. The construct includes a glucose responsive regulatory module having at least one glucose inducible regulatory element comprising a pair of CACGTG motifs linked by a five base nucleotide sequence, which confers glucose inducible expression of the proinsulin coding sequence. To ensure proper processing of the proinsulin to active insulin, the coding sequence was modified to direct the synthesis of a mutant proinsulin polypeptide having amino acid sequences that can be cleaved to mature insulin in suitable host cells, such as hepatocytes.
Methods And Compositions For The Detection Of Complications Of Diabetes
US Patent:
2013033, Dec 19, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/838428
Inventors:
Hans Sollinger - Madison WI, US
Debra A. Hullett - Oregon WI, US
Debra A. Hullett - Oregon WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
G01N 33/50
US Classification:
506 9, 435 29, 435 792, 435 71
Abstract:
The present disclosure provides methods and compositions for determining the presence of or predisposition to insulin resistance, diabetes, and complications of diabetes in a subject. The methods relate to measuring the capacity of a subject's peripheral blood mononuclear cells (PBMCs) to induce physiological and/or morphological changes characteristic of fibrosis in cultured.
Use Of Vitamin D Compounds To Prevent Transplants Rejection
US Patent:
2003022, Dec 4, 2003
Filed:
Mar 13, 2003
Appl. No.:
10/240029
Inventors:
Hector Deluca - Deerfield WI, US
Bryan Becker - Verona WI, US
Hans Sollinger - Madison WI, US
Debra Hullett - Oregon WI, US
Bryan Becker - Verona WI, US
Hans Sollinger - Madison WI, US
Debra Hullett - Oregon WI, US
International Classification:
A61K031/59
US Classification:
514/167000
Abstract:
A method of stabilizing kidney function in transplant patients is disclosed. In one embodiment, the method comprises the steps of kidney transplant patient, wherein the transplant patient is undergoing immunosuppressive therapy, with a sufficient amount of vitamin D compound whereby the kidney function stabilizes.
Treatment Of Diabetes With Synthetic Beta Cells
US Patent:
2007028, Dec 6, 2007
Filed:
Aug 23, 2004
Appl. No.:
10/923924
Inventors:
Tausif Alam - Madison WI, US
Debra Hullett - Madison WI, US
Hans Sollinger - Madison WI, US
Debra Hullett - Madison WI, US
Hans Sollinger - Madison WI, US
International Classification:
A61K 35/76, A61K 31/7052, A61P 3/08, C12N 15/63, C12N 15/86, C12N 5/08, C12N 7/01
US Classification:
424093600, 435235100, 435320100, 435370000, 435455000, 435456000, 514044000
Abstract:
Disclosed is a method for obtaining glucose-regulated expression of active insulin in the cells of a mammalian subject. The method involves delivering into the subject a genetic construct comprising a coding sequence for a human proinsulin operably connected a promoter functional in the host cells. The construct includes a glucose responsive regulatory module having at least one glucose inducible regulatory element comprising a pair of CACGTG motifs linked by a five base nucleotide sequence, which confers glucose inducible expression of the proinsulin coding sequence. To ensure proper processing of the proinsulin to active insulin, the coding sequence was modified to direct the synthesis of a mutant proinsulin polypeptide having amino acid sequences that can be cleaved to mature insulin in suitable host cells, such as hepatocytes.
Vitamin D Compounds Used To Stabilize Kidney Transplants
US Patent:
2008002, Jan 24, 2008
Filed:
Jun 20, 2007
Appl. No.:
11/765947
Inventors:
Hector DeLuca - Deerfield WI, US
Bryan Becker - Verona WI, US
Hans Sollinger - Madison WI, US
Debra Hullett - Oregon WI, US
Bryan Becker - Verona WI, US
Hans Sollinger - Madison WI, US
Debra Hullett - Oregon WI, US
International Classification:
A61K 31/59, A61P 13/12
US Classification:
514167000
Abstract:
A method of stabilizing kidney function in transplant patients is disclosed. In one embodiment, the method comprises the steps of kidney transplant patient, wherein the transplant patient is undergoing immunosuppressive therapy, with a sufficient amount of vitamin D compound whereby the kidney function stabilizes and wherein the development of interstitial fibrosis is decreased.